List of works - Markus Riessland

CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis

scientific article published on 01 August 2018

Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing

scientific article published on 27 February 2010

Drug discovery for spinal muscular atrophy

scientific article published on 01 April 2007

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy

scientific article published on 03 March 2014

Experience-dependent translational state defined by cell type-specific ribosome profiling

Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases.

scientific article published on January 2013

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

scientific article published in July 2006

Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy

scientific article published on 10 April 2013

Investigational therapies for the treatment of spinal muscular atrophy.

scientific article published on 24 April 2015

Is there hope for spinal muscular atrophy synthetic pharmacotherapy?

scientific article published on 20 March 2019

Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy.

scientific article published on 18 January 2010

PLS3 mutations in X-linked osteoporosis with fractures

scientific article

Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.

scientific article published on 20 December 2012

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy

scientific article published on 12 August 2011

SMN regulates axonal local translation via miR-183/mTOR pathway

scientific article

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition

scientific article

The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype

scientific article published on 03 August 2016

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells

scientific article (publication date: August 2006)

List of works by Markus Riessland

CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis

Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing

Drug discovery for spinal muscular atrophy

Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy

Experience-dependent translational state defined by cell type-specific ribosome profiling

Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases.

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy

Investigational therapies for the treatment of spinal muscular atrophy.

Is there hope for spinal muscular atrophy synthetic pharmacotherapy?

Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy.

PLS3 mutations in X-linked osteoporosis with fractures

Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy

SMN regulates axonal local translation via miR-183/mTOR pathway

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition

The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells